晚期鼻腔鼻窦腺样囊性癌12例临床分析
作者:

Advanced sinonasal adenoid cystic carcinoma: a clinical analysis of 12 cases
Author:
  • 摘要
  • | |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • | |
    摘要:

    目的总结原发于鼻腔鼻窦的晚期腺样囊性癌(ACC)的临床特征,探讨切缘病检结果以及复发或转移与预后的关系。方法回顾性分析12例晚期鼻腔鼻窦ACC患者的临床资料、治疗方法及预后。其中T3和T4期病变患者各6例,均无局部淋巴结及全身转移。首次治疗均以手术为主,9例联合术后放疗,4例联合化疗,复发及转移的治疗方式各异,仍以再手术为主。结果在20次首发及复发病灶的手术中,切缘阳性率高(75%,15/20),切缘阳性者生存时间最长达32年;随访期间局部复发7例(2例合并远处转移),单纯远处转移1例,局部复发并远处转移患者最长生存达32年。结论晚期鼻腔鼻窦ACC手术切缘阳性率高,局部复发率高,但局部复发或远处转移后仍能带瘤生存较长时间,在行根治性手术以及复发或转移治疗决策时应充分考虑患者的生存质量。

    Abstract:

    ObjectiveTo summarize the clinical features of advanced sinonasal adenoid cystic carcinoma(ACC), and to explore the relationship between surgical margin, recurrence or metastasis and prognosis.MethodsThe clinical data, treatment and prognosis of 12 patients with advanced sinonasal ACC were analyzed retrospectively. Among them, all of 6 patients with T3 and 6 patients with T4 were not local lymph node and systemic metastases. All patients underwent surgery as initial treatment, 9 cases combined with postoperative radiotherapy and 4 cases combined with chemotherapy. The treatment of them were various when local recurrence or distant metastasis.ResultsThe positive rate of surgical margin was high (75%, 15/20) in 20 cases of initial and recurrent lesions. And those with positive surgical margins were surviving up to 32 years.During the follow-up period, there were 7 cases of local recurrence (2 cases with distant metastasis) and 1 case of simple distant metastasis. The longest survival of patients with local recurrence and distant metastasis was 32 years.ConclusionAdvanced sinonasal ACC has a high positive surgical margin rate and a high local recurrence rate. However, the patients can still survive with tumor for a long time after local recurrence or distant metastasis, and the patient's survival quality should be fully considered when making decisions on radical surgery and treatment of recurrence or metastasis.

    网友评论
    网友评论
    分享到微博
    发 布
    参考文献
    [1] Papaspyrou G, Hoch S, Rinaldo A, et al. Chemotherapy and targeted therapy in adenoid cystic carcinoma of the head and neck: a review[J]. Head Neck, 2011, 33(6): 905-911.
    [2] Unsal AA, Chung SY, Zhou AH, et al. Sinonasal adenoid cystic carcinoma: a population-based analysis of 694 cases[J]. Int Forum Allergy Rhinol, 2017, 7(3): 312-320.
    [3] Husain Q, Kanumuri VV, Svider PF, et al. Sinonasal adenoid cystic carcinoma: systematic review of survival and treatment strategies[J]. Otolaryngol Head Neck Surg, 2013, 148(1): 29-39.
    [4] Ali S, Yeo JC, Magos T, et al. Clinical outcomes of adenoid cystic carcinoma of the head and neck: a single institution 20-year experience[J]. J Laryngol Otol, 2016, 130(7): 680-685.
    [5] Rhee CS, Won TB, Lee CH, et al. Adenoid cystic carcinoma of the sinonasal tract: treatment results[J]. Laryngoscope, 2006, 116(6): 982-986.
    [6] Thompson LD, Penner C, Ho NJ, et al. Sinonasal tract and nasopharyngeal adenoid cystic carcinoma: a clinicopathologic and immunophenotypic study of 86 cases[J]. Head Neck Pathol, 2014, 8(1): 88-109.
    [7] Sanghvi S, Patel NR, Patel CR, et al. Sinonasal adenoid cystic carcinoma: comprehensive analysis of incidence and survival from 1973 to 2009[J]. Laryngoscope, 2013, 123(7): 1592-1597.
    [8] Seong SY, Hyun DW, Kim YS, et al. Treatment outcomes of sinonasal adenoid cystic carcinoma: 30 cases from a single institution[J]. J Craniomaxillofac Surg, 2014, 42(5): e171-175.
    [9] Lupinetti AD, Roberts DB, Williams MD, et al. Sinonasal adenoid cystic carcinoma: the M. D. Anderson Cancer Center experience[J]. Cancer, 2007, 110(12): 2726-2731.
    [10] Choi Y, Kim SB, Yoon DH, et al. Clinical characteristics and prognostic factors of adenoid cystic carcinoma of the head and neck[J]. Laryngoscope, 2013, 123(6): 1430-1438.
    [11] Amit M, Binenbaum Y, Sharma K, et al. Analysis of failure in patients with adenoid cystic carcinoma of the head and neck. An international collaborative study[J]. Head Neck, 2014, 36(7): 998-1004.
    [12] Jang S, Patel PN, Kimple RJ, et al. Clinical outcomes and prognostic factors of adenoid cystic carcinoma of the head and neck[J]. Anticancer Res, 2017, 37(6): 3045-3052.
    [13] Michel G, Joubert M, Delemazure AS, et al. Adenoid cystic carcinoma of the paranasal sinuses: retrospective series and review of the literature[J]. Eur Ann Otorhinolaryngol Head Neck Dis, 2013, 130(5): 257-262.
    [14] van Weert S, Reinhard R, Bloemena E, et al. Differences in patterns of survival in metastatic adenoid cystic carcinoma of the head and neck[J]. Head Neck, 2017, 39(3): 456-463.
    [15] Singh FM, Mak SY, Bonington SC. Patterns of spread of head and neck adenoid cystic carcinoma[J]. Clin Radiol, 2015, 70(6): 644-653.
    [16] Coca-Pelaz A, Rodrigo JP, Bradley PJ, et al. Adenoid cystic carcinoma of the head and neck-An update[J]. Oral Oncol, 2015, 51(7): 652-661.
    [17] Ikawa H, Koto M, Takagi R, et al. Prognostic factors of adenoid cystic carcinoma of the head and neck in carbon-ion radiotherapy: The impact of histological subtypes[J]. Radiother Oncol, 2017, 123(3): 387-393.
    [18] Balamucki CJ, Amdur RJ, Werning JW, et al. Adenoid cystic carcinoma of the head and neck[J]. Am J Otolaryngol, 2012, 33(5): 510-518.
    [19] Wardas P, Tymowski M, Piotrowska-Seweryn A, et al. Endoscopic approach to the resection of adenoid cystic carcinoma of paranasal sinuses and nasal cavity: case report and own experience[J]. Eur J Med Res, 2015, 20: 97.
    [20] Lloyd S, Yu JB, Wilson LD, et al. Determinants and patterns of survival in adenoid cystic carcinoma of the head and neck, including an analysis of adjuvant radiation therapy[J]. Am J Clin Oncol, 2011, 34(1): 76-81.
    [21] Ellington CL, Goodman M, Kono SA, et al. Adenoid cystic carcinoma of the head and neck: Incidence and survival trends based on 1973-2007 Surveillance, Epidemiology, and End Results data[J]. Cancer, 2012, 118(18): 4444-4451.
    [22] Amit M, Binenbaum Y, Sharma K, et al. Adenoid cystic carcinoma of the nasal cavity and paranasal sinuses: a meta-analysis[J]. J Neurol Surg B Skull Base, 2013, 74(3): 118-125.
    [23] Marcinow A, Ozer E, Teknos T, et al. Clinicopathologic predictors of recurrence and overall survival in adenoid cystic carcinoma of the head and neck: a single institutional experience at a tertiary care center[J]. Head Neck, 2014, 36(12): 1705-1711.
    [24] Dillon PM, Chakraborty S, Moskaluk CA, et al. Adenoid cystic carcinoma: A review of recent advances, molecular targets, and clinical trials[J]. Head Neck, 2016, 38(4): 620-627.
    [25] 孔琳, 陆嘉德. 头颈部恶性肿瘤的质子、重离子治疗实践[J]. 中华放射肿瘤学杂志, 2016, 25(5): 427-431.
    [26] 高晶, 孔琳, 管西寅, 等. 质子碳离子治疗腺样囊性癌的近期疗效及不良反应[J]. 中华放射医学与防护杂志, 2016, 36(8): 607-610.
    引证文献
引用本文

何观文,王全桂,肖水芳,秦永,赵恩民,郭敏.晚期鼻腔鼻窦腺样囊性癌12例临床分析[J].中国耳鼻咽喉颅底外科杂志,2022,28(5):92-96

复制
分享
文章指标
  • 点击次数:429
  • 下载次数: 205
历史
  • 收稿日期:2021-10-11
  • 在线发布日期: 2022-11-01
温馨提示

本刊唯一投稿网址:www.xyosbs.com
唯一办公邮箱:xyent@126.com
编辑部联系电话:0731-84327210,84327469
本刊从未委托任何单位、个人及其他网站代理征稿及办理其他业务联系,谨防上当受骗!

关闭